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LETTERS 
Alpha-methyldopa-induced systemic vasculitis 
confused with Wegener’s granulomatosis 
To the Editor: 
Alpha-methyldopa was introduced as an antihyper- 
tensive drug in 1960. Side effects of its administration have 
included dry mouth, fever, gastrointestinal upset, positive 
results on antinuclear antibody (ANA) tests and lupus ery- 
thematosus cell preparations, granulocytopenia and throm- 
bocytopenia, positive direct Coombs’ test results, hemolytic 
anemia, and serious hepatic injury ( I  ,2). 
We report a case of acute hepatic injury and systemic 
granulomatous disease mimicking Wegener’s granulomato- 
sis (WG) occurring I 1  days after initiation of therapy with 
alpha-methyldopa for essential hypertension. 
The patient, a 48-year-old white man, experienced 
the sudden onset of migratory rnyalgias, fatigue, nightly 
fevers (103°F orally), and drenching night sweats. One week 
later, symptoms of arthritis developed-swelling and stiff- 
ness of the wrists, fingers, and knees, as well as bilateral 
conjunctival injection. These symptoms occurred 11 days 
after methyldopa (250 mg twice daily orally) was substituted 
for the previous regimen of hydrochlorothiazide and atenolol 
to improve blood pressure control; they persisted for 6 
weeks after the methyldopa therapy was discontinued. For 
the preceding 2 years, the patient had also been taking 
allopurinol(lO0 mg twice daily orally) for hyperuricemia and 
presumed gout. 
In the subsequent 3 weeks, the patient experienced a 
5-lb weight loss, worsening vision, frontal and occasionally 
bitemporal headache, and an erythematous, macular, non- 
pruritic rash on  the trunk, which faded after 10 days. At the 
time of hospitalization, the methyldopa was discontinued 
because “adequate blood pressure control” had been 
achieved. Physical examination revealed the truncal rash as 
well as a liver span of 20 cm in the midclavicular line. 
Bilateral scleral and corneal ulcerations were seen. The 
pupils were dilated to 6 7  mm and unresponsive to light. 
There was anesthesia of the cornea, nasal vestibules, and 
labial folds. 
Laboratory evaluation revealed a mild anemia. Liver 
enzymes were elevated up to 6 times normal levels. Uri- 
nalysis and renal function test results were normal. Total 
hemolytic complement was profoundly decreased. Wester- 
gren erythrocyte sedimentation rate was 76 mm/hour. Re- 
sults of a VDRL test, Monospot test, tests for ANA and 
rheumatoid factor, as well as bacterial, viral, fungal, and 
mycobacterial cultures of blood, bone marrow, liver, spu- 
tum, and stool were negative. Results of a chest radiograph 
were normal. Computed tomography of the head revealed 
only a mucous retention cyst in the right maxillary sinus. A 
temporal artery biopsy specimen was normal. A random 
nasal biopsy from the right medial turbinate (which healed 
well) revealed necrotizing granulomatous inflammation 
with vasculitis. Liver biopsy showed necrosis and granulo- 
matous inflammation with widespread hepatocyte dropout 
(Figure 1) .  
The patient was diagnosed as having WG and was 
transferred for initiation of immunosuppressive therapy. 
However, it was decided instead to observe the patient 
before beginning this treatment, and during the next 3 
Figure 1. Liver biopsy specimen from a patient with alpha- 
methyldopa-induced systemic vascu!itis. There are wide areas of 
hepatocyte dropout. Focally, neutrophils are admixed with epithe- 
lioid cells (hematoxylin and eosin stained. original magnification x 
250). 
weeks, the symptoms abated. Results of the physical exam- 
ination returned to normal, as did the abnormal laboratory 
parameters. No specific therapy, including cytotoxic drugs, 
steroids, or nonsteroidal agents, was administered for this 
condition. 
In the recorded cases of hepatic disease resulting 
from alpha-methyldopa, the onset of the disease was acute in 
85% of patients and chronic in the remainder (2). Histologic 
features of acute methyldopa-induced liver injury range from 
a mild nonspecific portal and periportal inflammation to an 
acute, sometimes fulminant hepatocellular injury resembling 
acute viral hepatitis (3,4). Cellular degeneration, “free” 
acidophilic bodies, and areas of necrosis are characteristic 
features. The inflammatory response tends to be concen- 
trated in the portal and periportal zones and consists mainly 
of lymphocytes and other mononuclear cells with some 
neutrophils. Tissue eosinophilia is uncommon (2). Bridging 
necrosis extending between portal areas and from portal to 
central areas also occurs (3). 
Granulomatous hepatitis is not an unusual character- 
istic of drug-induced hepatotoxicity (5) .  Granulomatous in- 
flammation is well recognized in the spectrum of vasculitic 
diseases (6), and in this patient may represent a manifestation 
of a systemic vasculitis that was initially confused with WG. 
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Although the patient had symptoms and physical and 
histologic features of WG, we suggest the illness was caused 
by methyldopa. Most important, the patient had no evidence 
of pulmonary or renal involvement, and the disorder re- 
solved without the use of steroids or cytotoxic agents. 
Allopurinol can also cause severe hepatic disease, 
occurring chiefly in patients with renal insufficiency (7). 
However, the time course of the disease and the normal 
renal function in this patient provide evidence against allo- 
purinol as the causative agent. Synergy between allopurinol 
and methyldopa leading to this reaction is a possible, but not 
previously reported, mechanism of toxicity. 
Eric L. Matteson, MD 
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Participation of synovial mast cells in intermittent 
hydrarthrosis 
To the Editor: 
Recent studies have implicated synovial mast cells in 
the development and/or perpetuation of synovitis and joint 
tissue destruction (1). We treated a patient with intermittent 
hydrarthrosis in whom measurements of plasma and syno- 
vial fluid (SF) histamine concentration, together with a 
complete response to intraarticular steroid injection, provide 
evidence for the participation of synovial mast cells in this 
condition. 
The patient, a 32-year-old white woman, had an 
approximately 3-year history of knee arthritis. Her  left knee 
became painful with effusion every 10 days, remained in- 
flamed for about 48 hours, and spontaneously returned to 
normal. For the next 8 or 9 days, the knee would be 
completely free of effusion and pain, only to  become 
inflamed again on  approximately day 9. The right knee 
demonstrated an identical periodic pattern of involvement, 
except for being 3 days “out of phase” with the left knee. 
History, physical examination, and laboratory studies (sero- 
logic studies, erythrocyte sedimentation rate, complete 
blood count, radiographs, and culture and examination of SF 
Table 1. 
from a patient with intermittent hydrarthrosis* 
Histamine concentrations in plasma and synovial fluid 
Date 
Plasma histamine Synovial fluid 
(pglml) histamine (pglml) 
8/5/86 









N D  
120 + 10 
500 i 16 
390 + 17 
110+ 1 
0 2 32 
90 2 16 
0 2  17 
130 + 20 
0 + 5  
640 2 45 
490 + 93 
1,270 + 57 
0 r 17 
0 2 39 
0 2 7  
0 2 7  
0 + 6  
0 2 5  
520 2 30 
~~ 
* Measurements were taken during the course of the arthritis 
attacks. Values are the mean t SEM. ND = not done. 
for crystals) failed to reveal a cause of the arthritis. The SF 
typically contained 4 , 0 0 0  white blood cells (WBC)/mm3. 
Differential cell counts revealed that up to 90% of the WBC 
in the fluid were “histiocytes” (actually predominantly 
synovial lining cells), the balance being lymphocytes and 
polymorphonuclear cells. Noting these findings, and the 
undeviating regularity of the attacks, we made a clinical 
diagnosis of intermittent hydrarthrosis ( 2 ) .  
The paroxysmal and transient nature of these attacks 
suggested to  us  that mast cell d e g r a d a t i o n  might be in- 
volved in the pathogenesis of the symptoms. The patient 
agreed to come to the clinic during her attacks of arthritis for 
simultaneous arthrocentesis and venous blood sampling for 
measurement of histamine. The results of these measure- 
ments are shown in Table 1. 
In each instance in which the S F  histamine concen- 
tration was measurable, it was higher than the concentration 
in simultaneously drawn plasma, indicating local release of 
histamine. Since virtually nothing is known about histamine 
kinetics in SF, and the patient came to  the clinic at varying 
times after the onset of symptoms, it is difficult to  interpret 
the measurements in which SF histamine was not detectable. 
In such instances. it is possible that the histamine had been 
completely metabolized before the samples were taken. 
Therapy with oral administration of several nonste- 
roidal antiinflammatory agents failed to alleviate her symp- 
toms. Data on the use of antihistamine drugs for arthritis are 
scant and anecdotal, so such therapy was not attempted. 
There is evidence, however, that intraarticular steroid injec- 
tion markedly decreases the number of stainable synovial 
mast cells (1). so we elected to  treat one knee with 40 mg of 
intraarticular triamcinolone acetonide. Injection of the left 
knee immediately suppressed attacks of arthritis in that 
joint, while the periodic attacks in the right knee continued 
without alteration. One month after the injection of the left 
knee, the right knee was similarly treated, and attacks in that 
joint abruptly ceased. The patient remained asymptomatic 
for approximately 10 months before knee swelling began 
anew. Several years previously, the patient had received an 
intraarticular steroid injection to  her symptomatic knee, and 
had experienced a symptom-free period of about I year. 
